http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275212-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5655b1d2b3894fa96dc42b2fed95a8e0 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a9848ba8451b3da17fcbd3d65a27a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4087e47044d27cc8fd818bc55376d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e516d3ca859186f5995aca689606c55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05372a84370e50e37bcd56437f6ad183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff57457135470741c7ab6bde6b1412c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7c40f89ce325911cf82418dc8edabec |
| publicationDate | 2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103275212-B |
| titleOfInvention | Antihuman CD146 monoclone antibody, composition containing same, and method for testing dissolubility CD146 |
| abstract | The invention relates to a group of antihuman CD146 molecules which are developed by utilizing the biological technology and an established high-sensitive sandwich ELISA method for detecting the solubility CD146. The invention includes antihuman CD146 mouse monoclonal antibodies of AA1, AA2, AA3, AA4, AA5 and AA7, and the method of utilizing the combination of the antibodies and the sandwich ELISA specificity for detecting the solubility CD146. The group of antibodies can identify the human source CD146 on molecular, cellular and tissue levels, and the human source CD146 can be divided into two categories based on the identified different epitopes. The sandwich ELISA method which is combined by the antibody AA1 and another strain of antihuman CD146 mouse monoclonal antibody AA98 can detect the solubility CD146 at each milliliter nano-gram level. The antibodies and the detection means can become effective detection or diagnosis tools and methods in the basic research or the clinical application, and can provide good carriers for the targeted therapy of the CD146-related diseases at the same time. |
| priorityDate | 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.